Okapi Venture Capital — 2018 Investments
1 investments dated 2018 · listed companies and verified rows first · show all
Obalon Therapeutics, Inc.Aug 2018
BiotechCarlsbad, US
Mark Brister(Chief Technology Officer)Kelly Huang, Ph.D.(Chief Operating Officer)William J. Plovanic(Chief Financial Officer)Andrew Rasdal(President and Chief Executive Officer)Les Howe(Director)Douglas Fisher(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.